Lai Wong
Patrimonio netto: 37 655 $ in data 31/05/2026
Patrimonio netto: 37 655 $ in data 31/05/2026
Lai Wong currently works at CIMC Enric Holdings Ltd., as Independent Non-Executive Director from 2023, ENN Energy Holdings Ltd., as Independent Non-Executive Director from 2023, Binhui Biopharmaceutical Co., Ltd., as Independent Non-Executive Director from 2025, and Transpac Capital Ltd., as Partner.
Ms. Wong received her undergraduate degree from London Metropolitan University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/11/2025 | 34.000 ( 0% ) | 37 655 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ENN ENERGY HOLDINGS LIMITED | Direttore/Membro del Consiglio | 25/08/2023 |
| CIMC ENRIC HOLDINGS LIMITED | Direttore/Membro del Consiglio | 24/08/2023 |
Transpac Capital Ltd. | Corporate Officer/Principal | - |
Wuhan Binhui Biopharmaceutical Co., Ltd.
Wuhan Binhui Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer immunotherapies | Direttore/Membro del Consiglio | 16/09/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
CIMC Enric Holdings Ltd.
CIMC Enric Holdings Ltd. Industrial MachineryProducer Manufacturing Operates as a holding company whose subsidiaries manufactures and wholesales equipment for the storage, transportation, processing and distribution of natural gas | Producer Manufacturing |
ENN Energy Holdings Ltd.
ENN Energy Holdings Ltd. Gas DistributorsUtilities Distributes natural gas and energy | Utilities |
London Metropolitan University
London Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transpac Capital Ltd. | |
Wuhan Binhui Biopharmaceutical Co., Ltd.
Wuhan Binhui Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer immunotherapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale